Richard Vosser
Stock Analyst at JP Morgan
(1.64)
# 2,190
Out of 4,415 analysts
7
Total ratings
60%
Success rate
13.71%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOR MorphoSys AG | Maintains: Overweight | $10 → $8.5 | $17.87 | -52.43% | 3 | Dec 5, 2023 | |
| MOLN Molecular Partners AG | Maintains: Neutral | $6.6 → $4.5 | $3.77 | +19.52% | 1 | Dec 5, 2023 | |
| NVO Novo Nordisk | Upgrades: Overweight | n/a | $124.02 | - | 2 | Jun 7, 2022 | |
| SNY Sanofi | Upgrades: Overweight | n/a | $49.46 | - | 1 | Jan 6, 2020 |
MorphoSys AG
Dec 5, 2023
Maintains: Overweight
Price Target: $10 → $8.5
Current: $17.87
Upside: -52.43%
Molecular Partners AG
Dec 5, 2023
Maintains: Neutral
Price Target: $6.6 → $4.5
Current: $3.77
Upside: +19.52%
Novo Nordisk
Jun 7, 2022
Upgrades: Overweight
Price Target: n/a
Current: $124.02
Upside: -
Sanofi
Jan 6, 2020
Upgrades: Overweight
Price Target: n/a
Current: $49.46
Upside: -